Annals On Call Podcast
American College of Physicians
Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.
Episodes
Mentioned books
Dec 15, 2025 • 25min
Complications Associated With Transvenous Cardiac Implantable Devices
Dr. Centor discusses complications of cardiac implantable electronic devices with Dr. Peter Zimetbaum.
Dec 1, 2025 • 25min
Cost-Effectiveness of Weight Loss Drugs for Knee Osteoarthritis
Dr. Centor discusses the use of weight loss drugs to treat patients with knee osteoarthritis with Dr. David Felson.
Nov 17, 2025 • 20min
Palliative Care: A Family Perspective
Dr. Centor discusses a family perspective on palliative care with Ms. Monica Wright, the author of an On Being a Patient essay.
Nov 3, 2025 • 16min
What You May Have Missed in 2024: Part 3
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Oct 20, 2025 • 14min
What You May Have Missed in 2024 - Part 2
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
Oct 6, 2025 • 29min
High-Concentration Cannabinoids: Are They Safe?
Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.
Sep 15, 2025 • 20min
What You May Have Missed in 2024: Part 1
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
7 snips
Sep 1, 2025 • 23min
Fibrillation - When Ablation is the Way to Go
Dr. Peter Zimetbaum, a leading expert in cardiovascular medicine from Harvard, delves into the growing prevalence of atrial fibrillation and the emerging role of ablation therapy. He discusses a compelling meta-analysis that highlights ablation's advantages over medication in reducing long-term stroke risk. Zimetbaum also shares insights on the innovative pulse-field ablation technique, which ensures safer, quicker procedures. Additionally, he addresses the integration of ablation for patients with heart failure and the importance of anticoagulation decisions post-procedure.
Aug 18, 2025 • 30min
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Join Dr. Centor as he speaks with Kevin Kip, VP for Clinical Analytics at the University of Pittsburgh, and Anum Saeed, Assistant Professor of Cardiology at UPMC. They delve into the intriguing study comparing semaglutide and empagliflozin for type 2 diabetes, highlighting critical outcomes such as mortality and cardiovascular events. They break down complex topics like emulating clinical trials using electronic health records and discuss how demographic factors influence treatment adherence. Their insights pave the way for future diabetes treatment strategies.
Aug 4, 2025 • 21min
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
